These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 28735039

  • 21. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V, Swiezbin K, Chaplin M, Hoefer G.
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S, Martin PR.
    Am J Drug Alcohol Abuse; 2018 May; 44(3):310-316. PubMed ID: 28829626
    [Abstract] [Full Text] [Related]

  • 24. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
    Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M.
    Expert Opin Pharmacother; 2017 Dec; 18(18):1987-1999. PubMed ID: 29183228
    [Abstract] [Full Text] [Related]

  • 25. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M.
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [Abstract] [Full Text] [Related]

  • 26. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
    Holland R, Maskrey V, Swift L, Notley C, Robinson A, Nagar J, Gale T, Kouimtsidis C.
    Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349
    [Abstract] [Full Text] [Related]

  • 27. Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine.
    Tripathi R, Dhawan A, Rao R, Mishra AK, Jain R, Sinha S.
    J Addict Med; 2020 Apr; 14(2):132-138. PubMed ID: 30964756
    [Abstract] [Full Text] [Related]

  • 28. Who receives heroin-assisted treatment? A comparison of patients receiving opioid maintenance treatment in Denmark.
    Melis F, Hesse M, Eide D, Thylstrup B, Tjagvad C, Brummer JE, Clausen T.
    Drug Alcohol Depend; 2024 Jan 01; 254():111051. PubMed ID: 38091901
    [Abstract] [Full Text] [Related]

  • 29. Characteristics and current clinical practices of opioid treatment programs in the United States.
    Jones CM, Byrd DJ, Clarke TJ, Campbell TB, Ohuoha C, McCance-Katz EF.
    Drug Alcohol Depend; 2019 Dec 01; 205():107616. PubMed ID: 31678836
    [Abstract] [Full Text] [Related]

  • 30. The effect of buprenorphine vs methadone on sleep breathing disorders.
    Adimi Naghan P, Setareh J, Malekmohammad M.
    Adv Respir Med; 2021 Dec 01; 89(4):439-443. PubMed ID: 33871044
    [Abstract] [Full Text] [Related]

  • 31. [Management of opioid maintenance treatments when analgesic treatments are required].
    Laprevote V, Geoffroy PA, Rolland B, Leheup BF, Di Patrizio P, Cottencin O, Schwan R.
    Presse Med; 2013 Dec 01; 42(7-8):1085-90. PubMed ID: 23518339
    [Abstract] [Full Text] [Related]

  • 32. Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.
    Zhu Y, Mooney LJ, Yoo C, Evans EA, Kelleghan A, Saxon AJ, Curtis ME, Hser YI.
    Drug Alcohol Depend; 2021 Nov 01; 228():108996. PubMed ID: 34555691
    [Abstract] [Full Text] [Related]

  • 33. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A, Patil D, Scheinberg K, Blackinton Gale R, Vayalapalli S, Casarella J, Drexler K.
    J Addict Dis; 2013 Nov 01; 32(3):244-51. PubMed ID: 24074190
    [Abstract] [Full Text] [Related]

  • 34. Pain and withdrawal are common among patients receiving medications for opioid use disorder and associated with pain catastrophizing, negative affect, and poor sleep.
    Berry MS, Dunn KE.
    Exp Clin Psychopharmacol; 2024 Aug 01; 32(4):386-391. PubMed ID: 38722586
    [Abstract] [Full Text] [Related]

  • 35. Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder.
    O'Connor A, Bowling N.
    J Correct Health Care; 2020 Jan 01; 26(1):17-26. PubMed ID: 31960750
    [Abstract] [Full Text] [Related]

  • 36. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ.
    Pharmacotherapy; 2017 Jul 01; 37(7):824-839. PubMed ID: 28543191
    [Abstract] [Full Text] [Related]

  • 37. Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients.
    Launonen E, Alho H, Kotovirta E, Wallace I, Simojoki K.
    Int J Drug Policy; 2015 Sep 01; 26(9):875-82. PubMed ID: 25934054
    [Abstract] [Full Text] [Related]

  • 38. Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.
    Besson J, Beck T, Wiesbeck G, Hämmig R, Kuntz A, Abid S, Stohler R.
    Swiss Med Wkly; 2014 Sep 01; 144():w13933. PubMed ID: 24706398
    [Abstract] [Full Text] [Related]

  • 39. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).
    Nordmann S, Lions C, Vilotitch A, Michel L, Mora M, Spire B, Maradan G, Morel A, Roux P, Carrieri MP, ANRS Methaville study group.
    Psychopharmacology (Berl); 2016 Apr 01; 233(7):1203-13. PubMed ID: 26753792
    [Abstract] [Full Text] [Related]

  • 40. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
    Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Mao J, Edwards RR, Samet JH.
    Drug Alcohol Depend; 2015 Aug 01; 153():286-92. PubMed ID: 26048638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.